Download PDF
Aktuelle Rheumatologie 2013; 38(03): 164-172
DOI: 10.1055/s-0033-1343493
Kasuistik
© Georg Thieme Verlag KG Stuttgart · New York

Adult-onset Still’s disease – Ist ein hoher Ferritinspiegel richtungweisend für die Differenzialdiagnose? 4 Fallbeschreibungen und Literaturübersicht

Adult-Onset Still’s Disease – Is a High Ferritin Level Evidence for the Differential Diagnosis? 4 Case Reports and a Literature Review
H.-J. Menne
1   Rheumatologische Schwerpunktpraxis Dortmund – Medizinischen Zentrum am St. Josefs-Hospital
› Author Affiliations
Further Information

Publication History

Publication Date:
17 June 2013 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Es werden 4 Patienten mit dem seltenen Krankheitsbild eines Morbus Still des Erwachsenen vorgestellt. Die Diagnosekriterien nach Yamaguchi waren erfüllt: Fieber, Arthralgien, Exanthem, Pharyngitis, Transaminasenerhöhung und Leukozytose. Der klinische Verlauf und die Schwierigkeiten der Differenzialdiagnose werden dargestellt. Bei erhöhtem Ferritinspiegel sind zunächst Erkrankungen, die mit einer Eisenüberladung einhergehen, auszuschließen. Liegt keine Eisenverwertungsstörung vor, sind vor allem Lymphome, HIV und Hämophogozytose-Syndrome sowie Drug-Induced Hypersensitivity Syndrom (DIHS, DRESS) in die Differenzialdiagnose einzubeziehen. An Hand der Literatur wird versucht, das extrem erhöhte Serumferritin als Makrophagenprodukt darzustellen. Die Höhe des Ferritinspiegels scheint einerseits von der Aktivität der Erkrankung abzuhängen, andererseits ist der Zeitpunkt der Bestimmung innerhalb des Krankheitsverlaufes entscheidend.

Abstract

A total of 4 patients with the rare adult-onset Still’s disease are presented. The diagnostic criteria of Yamaguchi were fulfilled in all patients: fever, arthralgia, rash, sore thoat, increase of transaminases and leukocytes. The clinical history and the difficulties of the differential diagnosis are described. In cases with high ferritin levels, other conditions causing hyperferritinaemia as well as lymphoma, HIV, hemophagocytosis and the rare drug-induced hypersensitivity syndrome (DIHS, DRESS) should be excluded. On the basis of literature reports, a discussion is presented about hyperferritinaemia as a product of macrophages. On the one hand, the level of ferritin seems to be dependent on the disease activity while, on the other hand, in particular it also depends on the time of examination.

Schlüsselwörter

Adult onset Still’s disease - Hyperferritinämie - Makrophagenaktivierung - glykolysiertes Ferritin - nicht klassischer lysosomaler Sekretionsweg

Key words

adult onset Still’s disease - hyperferritinaemia - macrophage activation - glycosylated human ferritin - non-classical lysosomal secretory pathway
 

  • Literatur

  • 1 Still G. On a form of chronic joint disease in children. Med Chir Trans 1897; 80: 47-65
    PubMedGoogle Scholar
  • 2 Bywaters EGL. Still’s disease in the adult. Ann Rheumatol Dis 1971; 30: 121-133
    CrossrefPubMedGoogle Scholar
  • 3 Yamaguchi M, Ohta A, Tsunematsu T et al. Preliminary criteria for classification of adult Still’s disease. J Rheum 1992; 19: 424-430
    PubMedGoogle Scholar
  • 4 Fautrel B, Zing E, Golmard JLP et al. Proposal for a new set of classification criteria for adult-onset still disease. Medicine (Baltimore) 2002; 81: 194-200
    CrossrefPubMedGoogle Scholar
  • 5 Manger B. Adult onset Still’s disease. Z Rheumatol 2008; 67: 415-422
    PubMedGoogle Scholar
  • 6 Evensen KJ, Nossent HC. Epidemiology and outcome of adult-onset Still’s disease in Northern Norway. Scand J Rheumatol 2006; 35: 48-51
    CrossrefPubMedGoogle Scholar
  • 7 Cagatay Y, Gul A, Cagatay A et al. Adult-onset Still’s disease. Int J Clin Pract 2009; 63: 1050-1055
    CrossrefPubMedGoogle Scholar
  • 8 Chen P-D, Yu S-L, Chen S et al. Retrospectiv study of 61 patients with adult-onset Still’s disease admitted with fever of unkown origin in China. Clin Rheumatol 2012; 31: 175-181
    CrossrefPubMedGoogle Scholar
  • 9 Colina M, Zucchini W, Ciancio G et al. The evolution of adult-onset still disease: an observational and comparative study in a cohort of 76 Italian patients. Semin Arthritis Rheum 2011; 41: 279-285
    CrossrefPubMedGoogle Scholar
  • 10 Cush JJ, Medsger TA, Christy WC et al. Adult-onset Still’s disease. Clinical Course and Outcome. Arth. Rheum 1987; 30: 186-194 Akritidis N. et al.: Very high serum ferritin levels in adult-onset Still’s disease. Br J Rheumatol 1997; 36:608-609
    CrossrefPubMedGoogle Scholar
  • 11 Franchini S, Dagna L, Salvo F et al. Adult onset Still’s disease: clinical presentation in a large cohort of Italian patients. Clin Exp Rheumatol 2010; 28: 41-48
    PubMedGoogle Scholar
  • 12 Masson C, Le Loet X, Lioté F et al. and the Task Force on Adult Still‘s disease. Part I. Manifestations and complications in sixty-five cases in France. Rev Rhum (Engl.Ed.). 1995. 62. 748-757
    Google Scholar
  • 13 Mock B, Hein G, Stein G. Still-Syndrom des Erwachsenen.- Ein Bericht über acht Fälle unter besonderer Berücksichtigung der diagnostischen Wertigkeit des Ferritins. Med Klinik 1997; 92: 515-520
    CrossrefPubMedGoogle Scholar
  • 14 Ohta A, Yamaguchi M, Kaneoka H et al. Adult Still’s disease: Review of 228 cases from the literature. J Rheumatol 1987; 14: 1139-1146
    PubMedGoogle Scholar
  • 15 Ohta A, Yamaguchi M, Tsumenatsu T et al. Adult Still’s disease: A multicentre survey of japanese patents. J Rheum 1990; 17: 1058-1063
    PubMedGoogle Scholar
  • 16 Pay S, Turkcapar N, Kalyoncu M et al. A multicenter study of patients with adult-onset Still’s disease compared with systemic juvenile idiopathic arthritis. Clin Rheumatol 2006; 25: 639-644
    CrossrefPubMedGoogle Scholar
  • 17 Pouchot J, Sampalis JS, Beaudet F et al. Adult Still’s Disease: Manifestations, Disease Course, and Outcome in 62 Patients. Medicine (Baltimore) 1991; 70: 118-136
    PubMedGoogle Scholar
  • 18 Reginato AJ, Schumacher jr HR, Baker DG et al. Adult onset Still´s Disease: experience in 23 Patients and literature review with emphasis on organ failure. Semin Arthr Rheum 1987; 17: 39-57
    CrossrefPubMedGoogle Scholar
  • 19 Riera E, Olivé A, Narváez J et al. Adult onset Still’s disease: review of 41 cases. Clin Exp Rheumatol 2011; 29: 331-336
    PubMedGoogle Scholar
  • 20 Wouters JMGW, van de Putte LBA. Adult-onset Still’s Disease; Clinical and Laboratory Features, Treatment and Progress of 45 Cases. Quarterly Journal of Medicine 1986; 61 (no. 235) 1055-1065
    PubMedGoogle Scholar
  • 21 Zeng T, Zou YQ, Wu MF et al. Clinical features and prognosis of adult-onset Still´s disease: 61 cases from China. J Rheumatol 2009; 36: 1026-1031
    CrossrefPubMedGoogle Scholar
  • 22 Ben m’rad M, Leclerc-Mercier St, Blanche P et al. Drug-Induced Hypersensitivity Syndrome Clinical and Biologic Disease Pattern in 24 Patients. Medicine 2009; 88: 131-140
    CrossrefPubMedGoogle Scholar
  • 23 Chen DY, Lan HHC, Hsieh TY et al. Crico-thyroid perichondritis leading to sore throat in patients with active adult-onset Still´s disease. Ann Rheum Dis 2007; 66: 1264-126
    CrossrefPubMedGoogle Scholar
  • 24 Dino O, Provenzano G, Giannuoli G et al. Fulminant Hepatic Failure in Adult Onset Still’s Disease. J Rheum 1996; 23: 784-785
    PubMedGoogle Scholar
  • 25 Choe JY, Chung DS, Park SH et al. Clinical significance of 18F-fluoro-deoxyglucose positron emission tomography in patients with adult onset Still’ds disease: report of two cases and review of literatures. Rheumatol Int 2010; 30: 1673-1676
    CrossrefPubMedGoogle Scholar
  • 26 Cantor JP, Douglas Pitcher W, Hurd E et al. Severe restrictive pulmonary Defect in a Patient with Adult-Onset Still’s Disease. Chest 1987; 92: 939-940
    CrossrefPubMedGoogle Scholar
  • 27 Akritidis N, Papdopoulos A, Pappas G. Long-term follow-uo of patients with adult-onset Still’s disease. Scand J Rheumatol 2006; 35: 395-397
    CrossrefPubMedGoogle Scholar
  • 28 Akritidis N, Giannakakis I, Giouglis T et al. Ferritin levels and response to treatment in patients with Adult Still’s disease. J Rheum 1996; 23: 201-202
    PubMedGoogle Scholar
  • 29 Elkon KB, Hughes GRV, Bywaters EGL et al. Adult-onset Still’s Disease. Twenty-Year Follow up and Further Studies of Patients with active Disease. Arth Rheum 1982; 25: 647-654
    CrossrefPubMedGoogle Scholar
  • 30 Uppal SS, Al-Mutairi M, Hayat S et al. Ten years of clinical experience with adult onset Still’s disease: Is the outcome improving?. Clin Rheumatol 2007; 26: 1055 -1060
    CrossrefPubMedGoogle Scholar
  • 31 Fujii T, Akizuki M, Kameda H et al. Methotrexate treatment in patients with adult onset Still’s Disease- retrospective study of 13 Japanese cases. Annals Rheum Dis 1997; 56: 144-148
    CrossrefPubMedGoogle Scholar
  • 32 Coffernils M, Soupart A, Pradier O et al. Hyperferritinämie in adult onset Still’s disease and the hemophagocytic syndrome. J Rheum 1992; 19: 1425-1427
    PubMedGoogle Scholar
  • 33 Lee MH, Robert jr M. Extremely elevated serum ferritin levels in a university hospital: associated diseases an clinical significance. Amer J Med 1995; 98: 566-571
    CrossrefPubMedGoogle Scholar
  • 34 Lian F, Wang Y, Yang X et al. Clinical features and hyperferritinemia diagnostic cutoff points for AOSD based on ROC curve: a Chinese experience. Rheumatol Int 2012; 32: 189-192
    CrossrefPubMedGoogle Scholar
  • 35 Félix FH, Leal LK, Fontenele JB. Cloak and dagger: the case for adult onset Still disease and hemophagocytic lymphohistiocytosis. Rheumatol Int 2009; 29: 973-974
    CrossrefPubMedGoogle Scholar
  • 36 Fukaya S, Yasuda S, Hashimoto T et al. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune disease: analysis of 30 cases. Rheumatology 2008; 47: 1686-1691
    CrossrefPubMedGoogle Scholar
  • 37 Fautrel B, Le Moël G, Saint-Marcoux B et al. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still’s disease. J Rheumatol 2001; 28: 322-329
    PubMedGoogle Scholar
  • 38 Van Reeth C, Le Moel G, Lasne Y et al. Serum ferritin and isoferritins are tools for diagnosis of active adult Still’s disease. J Rheum 1994; 21: 890-895
    PubMedGoogle Scholar
  • 39 Vignes St, Le Moel G, Fautrel B et al. Percentage of glycosylated serum ferritin in remains low throughout the cours of adult onset Still’s disease. Ann Rheum Dis 2000; 59: 347-350
    CrossrefPubMedGoogle Scholar
  • 40 Cohen LA, Gutierrez L, Weiss A et al. Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood 2010; 116: 1574 -1584
    CrossrefPubMedGoogle Scholar
  • 41 Ghosh S, Hevi S, Chuck SL. Regulated secretion of glycosylated human ferritin from hepatocytes. Blood 2004; 103: 2369-2376
    CrossrefPubMedGoogle Scholar
  • 42 Efthimiou P, Georgy S. Pathogenesis and management of adult-onset Still’s disease. Semin Arthrtis Rheum 2006; 36: 144-152
    PubMedGoogle Scholar
  • 43 Mehta B, Efthimiou P. Ferritin in Adult-onset Still’s disease: Just a Useful Innocent Bystander?. International Journal of Inflammation 2012 e-pub Artikel ID 298405
    PubMedGoogle Scholar
  • 44 Kwak EL, Larochelle DA, Beaumont C et al. Role for NF-kB in the Regulation of Ferritin H by Tumor Necrosis Factor-α. J Biol Chem 1995; 270: 15285-15293
    CrossrefPubMedGoogle Scholar
  • 45 Hoshino T, Ohta A, Yang D et al. Elevated Serum Interleukin 6, Inter-feron-γ, and Tumor Necrosis Factor-α Levels in Patients with adult onset Still’s disease. J Rheum 1998; 25, 2: 396-398
    PubMedGoogle Scholar
  • 46 Torti FM, Torti SV. Regulation of ferritin genes and proteins. Blood 2002; 99: 3505-3515
    CrossrefPubMedGoogle Scholar
  • 47 Colafrancesco S, Priori R, Alessandri C et al. IL-18 Serum Level in Adult Onset Still’s Disease: A Marker of Disease Activity. Int J of Inflammation 2012; ID 156890
    PubMedGoogle Scholar
  • 48 Kawashima M, Yamamura M, Taniai M et al. Levels of interleukin-18 and ist binding inhibitors in the blood circulation of patients with adult – onset Still’s disease. Arthritis Rheuma 2001; 44: 550-560
    CrossrefPubMedGoogle Scholar
  • 49 Maruyama J, Inokuma S. Cytokine profiles of macrophage activation syndrome associated with rheumatic diseases. J Rheumatol 2010; 37: 967-973
    CrossrefPubMedGoogle Scholar
  • 50 Priori R, Barone F, Alessandri C et al. Markedly increased IL-18 liver expression in adult-onset Still’s disease-related hepatitis. Rheumatology 2011; 50: 776-780
    CrossrefPubMedGoogle Scholar
  • 51 Conigliaro P, Priori R, Bombardieri M et al. Lymph node IL-18 expression in adult-onset Still´s disease. Ann Rheum Dis 2009; 68: 442-443
    CrossrefPubMedGoogle Scholar
  • 52 Chen DY, Lan JL, Lin FJ et al. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with activ, untreatezed adult-onset Still’s disease. Arthritis Rheum 2005; 53: 320-327
    CrossrefPubMedGoogle Scholar
  • 53 Swain SL. Interleukin 18: Tipping the Balance Towards a T Helper Cell 1 Response. J Exp Med. 2001 194. F11-F14
    PubMedGoogle Scholar
  • 54 Weiss G, Bogdan CH, Hentze MW. Pathways for the Regulation of Macrophage Iron Metabolism by the Anti-Inflammatory Cytokines IL-4 and IL-13. J Immun 1997; 158: 420-425
    PubMedGoogle Scholar
  • 55 Yokoi K, Hosoi E, Nakanishi M et al. Increased serum IgE level and interleukin-4 release from cultered lymphozytes from a patient with adult onset Still’s disease. Ann rheum Dis 1995; 54: 752-753
    CrossrefPubMedGoogle Scholar
  • 56 Recalcalcati S, Taramelli D, Conte D et al. Nitric oxide-mediated induction of ferritin synthesis in J774 macrophages by inflammatory cytokines: role of selective iron regulatory protein-2 downregulation. Blood 1998; 91,3: 1059-1066
    PubMedGoogle Scholar
  • 57 Hot A, Toh ML, Coppéré B et al. Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features and long-term outcome: a case-control study of 8 patients. Medicine (Baltimore) 2010; 89: 37-46
    CrossrefPubMedGoogle Scholar
  • 58 Stéphan F, Thiolière B, Verdy E et al. Role of Hemophagocytic in the Etiology of thrombocytopenia with Sepsis Syndrome or Septic Shock. Clin Infect Dis 1997; 25: 1159-1164
    CrossrefPubMedGoogle Scholar
  • 59 Kong X, Xu D, Zhang W et al. Clinical features and prognosis in adult-onset still’s disease a study of 104 cases. Clin Rheumatol 2010; 29: 1015-1019
    CrossrefPubMedGoogle Scholar
  • 60 Manger B, Rech J, Schett G. Use of methotrexate in adult-onset Still’s disease. Clin Exp Rheumatol. 2010. 28. 168-171
    Google Scholar
  • 61 Fautrel B, Sibilia J, Mariette X et al. Tumour necrosis factor alpha blocking agents in refractory adult Still’s disease: an observational study of 20 case. Ann Rheum Dis 2005; 64: 262-266
    CrossrefPubMedGoogle Scholar
  • 62 Laskari K, Tzioufas AG, Moutsopoulos HM. Efficacy and long-term follow-uo of IL-1R inhibitor anakinra in adults with Still’s disease: a case-series study. Arthritis Res Ther 2011; 13: R91
    CrossrefPubMedGoogle Scholar
  • 63 Lequerré T, Quartier P, Rosellini D et al. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann Rheum Dis 2008; 67: 302-308
    PubMedGoogle Scholar
  • 64 Puéchal X, DeBandt M, Berthelo JM et al. Tocilizumab in refractory adult Still’s disease. Arthritis Care Res 2011; 63: 155-159
    CrossrefPubMedGoogle Scholar
  • 65 Yoshida Y, Sakamoto M, Yokuta K et al. Tocilizumab improved both clinical and laboratory manifestations except for interleukin-18 in a case of multiple drug-resistant adult-onset Still´s disease. Intern Med 2011; 50: 1757-1760
    CrossrefPubMedGoogle Scholar
  • 66 Fautrel B. Adult-onset Still disease. Best Practice & Research Clinical Rheumatology 2008; 22: 773-792
    CrossrefPubMedGoogle Scholar
  • 67 Krüger K. Adulter Morbus Still – Off Label Therapie (Empfehlungen der DGRh) Abstract DGRh-Kongress. 2011; Thema Orphan diseases in der Rheumatologie 04: 01
    PubMedGoogle Scholar
  • 68 Ostrowski R, Tehrani R, Kadanoff R. Refractory Adult-Onset Still Disease Successfully Treated With Abatacept. J Clin Rheumatology 2011; 17: 315- 317
    PubMedGoogle Scholar